1st-of-its-kind drug for severe hot flashes during menopause approved by FDA



A newly permitted drug treats extreme scorching flashes attributable to menopause by blocking particular indicators within the mind, fairly than utilizing hormones like estrogen, the U.S. Meals and Drug Administration (FDA) introduced (opens in new tab) Friday (Might 12).

The tablet, referred to as Veozah (generic title fezolinetant), is the primary of its form permitted to deal with menopausal scorching flashes. Generally known as a “neurokinin 3 (NK3) receptor antagonist,” the drug successfully blocks NK3 receptors present in part of the mind referred to as the hypothalamus, an almond-size construction that regulates the physique’s hormone manufacturing and temperature, amongst different features.